Terms: = Sarcomas AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968 AND Prognosis
12 results:
1. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
2. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract] [Full Text] [Related]
3. Kaposi sarcoma at the base of the tongue in a renal transplant patient.
Safia A; Farhat R; Avraham Y; Merchavy S
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882263
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.
Yasutake N; Iwasaki T; Yamamoto H; Sonoda K; Kodama K; Okugawa K; Asanoma K; Yahata H; Kato K; Oda Y
Pathol Res Pract; 2022 Jul; 235():153920. PubMed ID: 35605413
[TBL] [Abstract] [Full Text] [Related]
6. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract] [Full Text] [Related]
7. High-grade uterine sarcoma with osteosarcomatous differentiation arising from a med12-mutated leiomyoma, a case report.
Le MK; Omori M; Oishi N; Oi M; Fukasawa H; Hirata S; Kondo T
Pathol Int; 2021 Mar; 71(3):199-203. PubMed ID: 33444473
[TBL] [Abstract] [Full Text] [Related]
8. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors.
Fujiwara S; Kawamoto T; Kawakami Y; Koterazawa Y; Hara H; Takemori T; Kitayama K; Yahiro S; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Koyanagi-Aoi M; Aoi T; Kuroda R; Akisue T
Stem Cell Res Ther; 2020 Oct; 11(1):429. PubMed ID: 33008481
[TBL] [Abstract] [Full Text] [Related]
9. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Tsuyoshi H; Yoshida Y
Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
[TBL] [Abstract] [Full Text] [Related]
10. Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma.
Yasutake N; Ohishi Y; Taguchi K; Hiraki Y; Oya M; Oshiro Y; Mine M; Iwasaki T; Yamamoto H; Kohashi K; Sonoda K; Kato K; Oda Y
Histopathology; 2018 Apr; 72(5):739-748. PubMed ID: 29077232
[TBL] [Abstract] [Full Text] [Related]
11. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract] [Full Text] [Related]
12. Case Report: A Low-grade Uterine Leiomyosarcoma Showing Multiple Genetic Aberrations Including a Bi-allelic Loss of the Retinoblastoma Gene Locus, as well as Germ-line Uniparental Disomy for Part of the Long Arm of Chromosome 22.
Holzmann C; Koczan D; Loening T; Rommel B; Bullerdiek J
Anticancer Res; 2017 May; 37(5):2233-2237. PubMed ID: 28476787
[TBL] [Abstract] [Full Text] [Related]
